Kidney disease patients have a variety of bone disorders that result in bone loss and fractures. The mechanisms of these bone disorders are not clear but may be related to abnormal modification of a bone protein known as collagen. Therefore, the investigators are conducting this research study to identify underlying mechanisms that are responsible for the disruption of bone collagen and determining whether the abnormal bone collagen impairs bone strength. The investigators intend to identify these mechanisms through studying relationships between kidney disease and bone strength via bone imaging, bone biopsy and non-invasive measures from blood and skin.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Determine amounts of abnormal collagen present in the bone of CKD patients
Timeframe: 2.5 years
Determine if greater amounts of abnormal collagen in the bone of CKD patients decreases bone strength
Timeframe: 1 year
To identify non-invasive biomarkers of advanced glycation end-products in bone collagen
Timeframe: 1 year